-
LIT-927
- names:
LIT-927
- CAS号:
2172879-52-4
MDL Number: - MF(分子式): C17H13ClN2O3 MW(分子量): 328.75
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM003631-10mg | 10mg | 99.66% | ¥ 2160.00 | ¥ 2160.00 | 2-3天 | ¥ 0.00 | ||
| YZM003631-5mg | 5mg | 99.66% | ¥ 1430.00 | ¥ 1430.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | |
| CAS号 | 2172879-52-4 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C17H13ClN2O3 |
| 分子量 Molecular Weight | 328.75 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度12.5 mg/mL(38.02 mM;Need ultrasonic)H2O< 0.1 mg/mL(insoluble) |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
LIT-927(CAS:2172879-52-4)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
| 产品说明 | LIT-927 为局部的、有口服活性的 CXC 趋化因子12(CXCL12)的中性配体,具有抗炎作用,对 CXCL12 结合到其受体 CXCR4 的Ki值为 267 nM |
| Introduction | LIT27 is a locally and orally activeCXCL12neutraligand with antinflammatory effect, with aKiof 267 nM for CXCL12 binding to its specific receptor CXCR4. |
| Application1 | |
| Application2 | |
| Application3 |
LIT-927 为局部的、有口服活性的 CXC 趋化因子12(CXCL12)的中性配体,具有抗炎作用,对 CXCL12 结合到其受体 CXCR4 的Ki值为 267 nM。LIT-927 is a locally and orally activeCXCL12neutraligand with anti-inflammatory effect, with aKiof 267 nM for CXCL12 binding to its specific receptor CXCR4[1].
【1】.Regenass P, et al. Discovery of a Locally and Orally Active CXCL12 Neutraligand (LIT-927) with Anti-inflammatory Effect in a Murine Model of Allergic Airway Hypereosinophilia. J Med Chem. 2018 Sep 13;61(17):7671-7686.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


